当前位置: 首页 » 论文全文
←返回首页
期刊信息:
《药学服务与研究》2013年, 第13卷, 第2期, 第98-102页
标题:
急性冠状动脉综合征出血评分系统在药学服务中的应用
DOI:
10.5428/pcar20130207
作者:
1. 冯侠侠(上海市嘉定区中心医院药剂科 上海 201800 fxx126@163.com)
摘要:
摘要  对CRUSADE和Integer出血评分系统进行比较,探讨它们在应对急性冠状动脉综合征患者治疗中防治缺血和出血时所起的作用。临床药师可利用这两个评分系统准确评估急性冠状动脉综合征患者的出血风险,为临床医师制定合理的治疗方案提供服务。
欢迎阅读《药学服务与研究》!您是该文第 1780 位读者!
若需在您的论文中引用此文,请按以下格式著录参考文献:
中文著录格式 冯侠侠. 急性冠状动脉综合征出血评分系统在药学服务中的应用[J]. 药学服务与研究. 2013; 13(2): 98-102.
英文著录格式 FENG XiaXia. Application of bleeding score systems in pharmaceutical care for acute coronary syndrome[J]. Pharmaceutical Care and Research / yao xue fu wu yu yan jiu. 2013; 13(2): 98-102.
参考文献:
1. 王蔚,葛均波.急性冠脉综合征治疗指南解读[J].中国处方药,2006,11(56):6-9.
2. Mehran R,Pocock S J,Stone G W,et al.Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes:a risk model from the ACUITY trial[J].Eur Heart J, 2009,30(12):1457-1466.
3. 急性冠状动脉综合征非血运重建患者抗血小板治疗中国专家共识组.急性冠状动脉综合征非血运重建患者抗血小板治疗的中国专家共识(修订案)[J].中华内科杂志,2009,48(9):793-798.
4. Moscucci M,Fox K A A,Cannon C P,et al.Predictors of major bleeding in acute coronary syndromes:the Global Registry of Acute Coronary Events(GRACE)[J].Eur Heart J,2003,24(20):1815-1823.
5. Subherwal S,Bach R G,Chen A Y,et al.Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction:the CRUSADE(Can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the ACC/AHA guidelines) bleeding score [J].Circulation,2009,119(14):1873-1882.
6. Mehran R,Pocock S J,Nikolsky E,et al.A risk score to predict bleeding in patients with acute coronary syndromes[J].J Am Coll Cardiol,2010,55(23):2556-2566.
7. The fifth organization to assess strategies in acute ischemic syndromes investigators,Yusuf S,Mehta S R,et al.Comparison of fondaparinux and enoxaparin in acute coronary syndromes[J].N Engl J Med,2006,354(14):1464-1476.
8. 中国医师协会心血管内科医师分会,中国老年学学会心脑血管病专业委员会,中国医师协会循证医学专业委员会.依诺肝素在急性冠状动脉综合征抗凝治疗的中国专家共识[J].中华内科杂志,2010,49(1):82-87.
9. US Food and Drug Administration.Proton pump inhibitors(PPI):class labeling change,including Nexium,Dexilant,Prilosec,Zegerid,Prevacid,Protonix,Aciphex,Vimovo,Prilosec OTC,Zegerid OTC,and Prevacid 24hr[EB/OL].(2010-05-25)[2012-06-10].http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm213321.htm.
10. US Food and Drug Administration.FDA drug safety podcast for healthcare professionals:low magnesium levels can be associated with long-term use of proton pump inhibitor drugs(PPIs)[EB/OL].(2011-03-02)[2012-06-10].http://www.fda.gov/Drugs/DrugSafety/DrugSafetyPodcasts/ucm245455.htm
11. Abraham N S,Hlatky M A,Antman E M,et al.ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines:a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents[J].J Am Coll Cardiol,2010,56(24):2051-2066.
12. Rassen J A,Choudhry N K,Avorn J,et al.Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome[J].Circulation,2009,120(23):2322-2329.
13. US Food and Drug Administration.Clopidogrel (marketed as Plavix) and omeprazole (marketed as Prilosec)-Drug Interaction[EB/OL].(2009-11-17)[2012-06-10].http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm190848.htm
14. US Food and Drug Administration.FDA reminder to avoid concomitant use of Plavix (clopidogrel) and omeprazole[EB/OL].(2010-10-27)[2012-06-10].http://www.fda.gov/Drugs/DrugSafety/ucm231161.htm
15. Juurlink D N,Gomes T,Ko D T,et al.A population-based study of the drug interaction between proton pump inhibitors and clopidogrel[J].CMAJ,2009,180(7):713-718.
16. 杨肖波,俞丽芬.质子泵抑制剂与氯吡格雷相互作用的临床研究及防治策略[J].国际消化病杂志,2010,30(5):293-296.
17. Bath P M W,Cotton D,Martin R H,et al.Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute,mild ischemic stroke:PRoFESS subgroup analysis[J].Stroke,2010,41(4):732-738.
18. Ozen I O,Moralioqlu S,Karabulut R,et al.Cefoperazone induced gastro-intestinal haemorrhage.A case report[J].Acta Chir Belg,2008,108(6):777-778.
19. Wong R S M,Cheng G,Chan N P H,et al.Use of cefoperazone still needs a caution for bleeding from induced vitamin K deficiency[J].Am J Hematol,2006,81(1):76.
20. 王艳宁,钟慧.头孢哌酮/舒巴坦钠致凝血功能障碍临床分析[J].中国药物应用与监测,2005,2(5):54-55.
21. 张小晋.非甾体抗炎药与胃肠道疾病[J].世界华人消化杂志,2008,16(27):3021-3025.